Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

GamaMabs Pharma doses first patient in Phase ll trial of GM102

Histopathologic image of colonic carcinoid stained by haematoxylin and eosin. Credit: KGH.

Go Top